FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

31210311000001108: Mepolizumab 100mg powder for solution for injection vials (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 03-Feb 2016. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
96074501000001115 Mepolizumab 100mg powder for solution for injection vials (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
96074601000001116 Mepolizumab 100mg powder for solution for injection vials en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

1 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Mepolizumab 100mg powder for solution for injection vials Has NHS dm+d (dictionary of medicines and devices) dose form indicator Discrete dose form indicator true Inferred relationship Existential restriction modifier
Mepolizumab 100mg powder for solution for injection vials Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Mepolizumab 100mg powder for solution for injection vials Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) route of administration Subcutaneous route true Inferred relationship Existential restriction modifier
Mepolizumab 100mg powder for solution for injection vials Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) ontology form and route solutioninjection.subcutaneous ontology form and route true Inferred relationship Existential restriction modifier
Mepolizumab 100mg powder for solution for injection vials Is a Mepolizumab true Inferred relationship Existential restriction modifier
Mepolizumab 100mg powder for solution for injection vials Is a Mepolizumab false Inferred relationship Existential restriction modifier
Mepolizumab 100mg powder for solution for injection vials Has dispensed dose form Powder for conventional release solution for injection true Inferred relationship Existential restriction modifier
Mepolizumab 100mg powder for solution for injection vials Has specific active ingredient Mepolizumab false Inferred relationship Existential restriction modifier
Mepolizumab 100mg powder for solution for injection vials VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Mepolizumab 100mg powder for solution for injection vials VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Mepolizumab 100mg powder for solution for injection vials Is a Virtual medicinal product true Inferred relationship Existential restriction modifier
Mepolizumab 100mg powder for solution for injection vials Has active ingredient Monoclonal antibody false Inferred relationship Existential restriction modifier
Mepolizumab 100mg powder for solution for injection vials Has specific active ingredient Mepolizumab true Inferred relationship Existential restriction modifier
Mepolizumab 100mg powder for solution for injection vials Has manufactured dose form Powder for conventional release solution for injection false Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Nucala 100mg powder for solution for injection vials (GlaxoSmithKline UK Ltd) Is a True Mepolizumab 100mg powder for solution for injection vials Inferred relationship Existential restriction modifier
Mepolizumab 100mg powder for solution for injection vials 1 vial Has VMP True Mepolizumab 100mg powder for solution for injection vials Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start